Abstract
Transdermal drug delivery is a validated technology contributing significantly to global pharmaceutical care. Since 1980, impressive growth in this field has been observed with many commercial successes; importantly, a new chemical entity was recently developed and approved for transdermal administration without having first been given as an injectable or oral dosage form. The progress achieved has been based on the clearer understanding of skin barrier function, and of the physicochemical, pharmacokinetic and physiological factors which underpin the feasibility of transdermal administration. Novel, non-invasive approaches to enhance and control drug transport across the skin are under intensive investigation, and some technologies, e.g. iontophoresis, have reached true maturity. The “local”, subcutaneous delivery of drugs (for example, to underlying muscle and other tissues) is gaining increasing acceptance, and new opportunities in this under-subscribed area may be envisaged.
This chapter is a modified version of the article “Transdermal Science and Technology – an Update,” published by R.H. Guy in Drug Delivery System, 22: 442–449 (2007).
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Altea Therapeutics (2008) http://www.alteatherapeutics.com
Bouwstra JA, Ponec M (2006) The skin barrier in healthy and diseased state. Biochim Biophys Acta 1758:2080–2095
Cork MJ, Robinson DA, Vasilopoulos Y, Ferguson A, Moustafa M, MacGowan A, Duff GW, Ward SJ, Tazi-Ahnini R (2006) New perspectives on epidermal barrier dysfunction in atopic dermatitis: gene-environment interactions. J Allergy Clin Immunol 118:3–21
Delgado-Charro MB, Guy RH (2001) Transdermal drug delivery. In: Hillery AM, Lloyd AW, Swarbrick J (eds) Drug Delivery and Targeting for Pharmacists and Pharmaceutical Scientists. Harwood Academic Publishers, London, pp 207–236
Dmochowski RR, Sand PK, Zinner NR, Gittelman MC, Davila GW, Sanders SW, Transdermal Oxybutynin Study Group (2003) Comparative efficacy and safety of transdermal oxybutynin and oral tolterodine versus placebo in previously treated patients with urge and mixed urinary incontinence. Urology 62:237–242
Guy RH (2003) “Minimally invasive” technologies for transdermal delivery and clinical chemistry. Challenge in Drug Delivery for the New Millenium. Bulletin Technique Gattefossé 96:47–61
Guy RH, Kalia YN, Delgado-Charro MB, Merino V, Lopez A, Marro D (2000) Iontophoresis: electrorepulsion and electro osmosis. J Control Release 64:129–132
Janssen-Cilag (2009) http://www.janssen-cilag.co.uk/product/detail.jhtml?itemname=ionsys_info
Karande P, Jain A, Ergun K, Kispersky V, Mitragotri S (2005) Design principles of chemical penetration enhancers for transdermal drug delivery. Proc Natl Acad Sci USA 102:4688–4693
Lee CM, Maibach HI (2006) Deep percutaneous penetration into muscles and joints. J Pharm Sci 95:1405–1413
Levin G, Gershonowitz A, Sacks H, Stern M, Sherman A, Rudaev S, Zivin I, Phillip M (2005) Transdermal delivery of human growth hormone through RF-microchannels. Pharm Res 22:550–555
Luzardo-Alvarez A, Delgado-Charro MB, Blanco-Méndez J (2001) Iontophoretic delivery of ropinirole hydrochloride: effect of current density and vehicle formulation. Pharm Res 18:1714–1720
Mitragotri S, Kost J (2004) Low-frequency sonophoresis: a review. Adv Drug Deliv Rev 56:589–601
Moser K, Kriwet K, Naik A, Kalia YN, Guy RH (2001) Passive skin penetration enhancement and its quantification in vitro. Eur J Pharm Biopharm 52:103–112
Mudry B, Guy RH, Delgado-Charro MB (2006) Iontophoresis in transdermal delivery. In: Touitou E, Barry BW (eds) Enhancement in Drug Delivery. Taylor and Francis, New York, NY, pp 279–302
Potts RO, Guy RH (1992) Predicting skin permeability. Pharm Res 9:663–669
Sieg A, Guy RH, Delgado-Charro MB (2005) Noninvasive and minimally invasive methods for transdermal glucose monitoring. Diabetes Technol Ther 7:174–197
Sivamani RK, Liepmann D, Maibach HI (2007) Microneedles and transdermal applications. Expert Opin Drug Deliv 4:19–25
Smith EW, Maibach HI (2005) Percutaneous penetration enhancers, 2nd edn. CRC Press, Boca Raton, FL
Thomas BJ, Finnin BC (2004) The transdermal revolution. Drug Discov Today 9:697–703
Vyteris (2008) http://www.vyteris.com/home/Our_Products/Lidosite.php
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2010 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Guy, R.H. (2010). Transdermal Drug Delivery. In: Schäfer-Korting, M. (eds) Drug Delivery. Handbook of Experimental Pharmacology, vol 197. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-00477-3_13
Download citation
DOI: https://doi.org/10.1007/978-3-642-00477-3_13
Published:
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-00476-6
Online ISBN: 978-3-642-00477-3
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)